Cite
Cognet M, Druais S, Gervais F, et al. Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK). Value Health. 2014;17(7):A549doi: 10.1016/j.jval.2014.08.1787.
Cognet, M., Druais, S., Gervais, F., Gauthier, A., & Abrams, K. R. (2014). Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A549. https://doi.org/10.1016/j.jval.2014.08.1787
Cognet, M, et al. "Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A549. doi: https://doi.org/10.1016/j.jval.2014.08.1787
Cognet M, Druais S, Gervais F, Gauthier A, Abrams KR. Cost of Previously Treated Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin's Lymphoma (INHL) in the United Kingdom (UK). Value Health. 2014 Nov;17(7):A549. doi: 10.1016/j.jval.2014.08.1787. Epub 2014 Oct 26. PMID: 27201785.
Copy
Download .nbib